Immunotherapy with BO-112, a novel double-stranded RNA-based agent, promotes tumor cell death and boosts T cell immunity in preclinical mouse models
- Resource Type
- Journal
- Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER ; NOV 7 2017, 5 1p. Supplement: 2- Subject
- Language
- English
- ISSN
- 20511426